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Background: Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) have significant impact on 
patients' lives and patient education is integral to the management of the diseases. 
Objectives: To assess the self-reported educational needs of patients with AS and PsA, and test 
differences across gender, age, disease duration and educational background. 
Methods: In this cross-sectional study, patients completed the Portuguese version of the 
Educational Needs Assessment Tool (PortENAT). Data was then Rasch-transformed to obtain 
interval-level measures of their educational needs which were summarized descriptively. Univariable 
analyses were used to determine differences between patient subgroups. 
Results: The study included 121 AS and 132 PsA patients (mean age =47.3 and 53.8 years; disease 
duration =15.6 and 14.4 years, respectively). Overall, patients with AS had higher educational needs 
than those with PsA (Table 1). On the domains' scores, age, gender and educational background had 
different effects in the disease groups; gender affected all domains, except treatments and support 
systems, with women expressing higher educational needs. Educational background had the 
strongest effect on overall score – higher education being related to higher educational needs. 
Conclusions: The educational needs vary by disease and demographic characteristics. Assessing 
individual patient education needs with tools such as the PortENAT may help target individual 
patient education. 
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Table 1. Educational needs by age, gender, disease duration, educational background and disease§ 
Domain (score range) Patients Disease Age Gender Disease duration Educational background 
   
Older Younger Male Female Longer Shorter Lower Higher 
Managing pain  
(0–24) 
AS 14.3±5.3 14.3±4.5 14.6±5.9 13.3±4.8* 15.6±5.5* 14.3±5.6 13.9±4.1 13.6±3.9 14.5±5.9 
 
PsA 13.3±6.4 12.3±7.0 14.2±5.5 12.3±6.5 14.0±6.1 13.0±6.7 14.4±5.3 11.9±6.9 15.7±5.7 
Movement (0–20) AS 10.6±3.9 10.9±3.4 10.4±4.3 9.7±3.6* 11.8±3.9* 10.9±3.9 9.5±3.3 11.0±3.3* 8.6±3.7* 
 
PsA 10.5±4.8 9.9±4.6 11.1±4.9 10.0±4.8 10.8±4.6 10.1±4.8 11.4±4.8 9.7±5.0 12.4±4.3 
Feelings (0–16) AS 9.6±3.8 9.5±3.4 9.5±4.0 8.6±3.8* 10.9±3.3* 9.8±3.6 9.0±4.2 10.6±3.1* 8.0±4.2* 
 
PsA 9.5±3.5 9.0±3.6 11.1±4.9 8.3±3.3* 10.6±3.3* 9.3±3.3 10.2±3.9 9.0±3.6* 11.4±4.8* 
Disease process (0–28) AS 18.2±5.6 17.7±5.5 18.9±5.4 17.6±5.6 19.1±5.5 18.3±5.7 19.0±5.3 17.6±5.6 17.8±5.2 
 
PsA 17.6±6.2 17.0±6.8 18.3±5.7 16.5±6.1* 18.6±6.0* 17.0±6.0* 19.8±6.3* 17.2±6.6 17.0±6.1 
Treatments (0–28) AS 14.6±5.2 14.0±4.3 14.9±5.9 14.0±5.1 15.4±5.2 14.4±5.3 15.0±5.1 15.5±3.9 12.9±6.5 
 
PsA 12.9±5.2 12.4±5.0 13.4±5.5 12.8±5.3 13.0±5.2 12.6±5.0 13.3±6.0 12.5±5.4 14.0±7.2 
Self-help measures (0–24) AS 14.8±5.3
#
 13.5±5.2* 16.1±5.3* 14.0±5.2* 16.0±5.3* 14.8±5.2 14.9±5.7 13.2±4.6 14.4±6.2 
 
PsA 12.8±6.1
#
 11.9±6.7 13.9±5.5 11.5±6.3* 14.0±5.5* 12.6±6.0 14.3±6.1 11.7±6.3* 16.8±6.1* 
Domain (score range) Patients Disease Age Gender Disease duration Educational background 
   
Older Younger Male Female Longer Shorter Lower Higher 
Support systems (0–16) AS 9.3±3.6
#
 9.0±3.3 9.7±3.7 8.8±3.6 10.1±3.5 9.6±3.4 8.8±3.6 9.6±3.2 8.2±3.1 
 
PsA 7.3±3.8
#
 7.3±4.3 7.5±3.5 6.6±3.5 7.9±3.9 7.4±3.8 7.5±3.5 7.3±4.3 6.7±3.4 
Total ENAT score (0–156) AS 88.6±23.2
#
 84.9±18.5 91.9±26.4 83.4±23.1* 96.0±21.5* 88.8±24.2 88.3±21.1 89.6±18.4 82.2±26.5 
 
PsA 79.7±26.5
#
 73.8±26.7* 85.3±25.5* 75.8±28.6 83.7±23.6 77.2±26.1 87.8±26.0 73.6±26.7* 93.9±32.9* 
 
§Values are mean ± standard desviation; age subgroups based on median split; disease duration categories based on split at 25th percentile. *Significant p-value 
(<0.05) for that parameter within disease, #Significant p-value (<0.05) for difference between diseases groups. 
